SUMMARY Research shows that cyanocobalamin may be absorbed better in your body, while methylcobalamin likely has a higher retention rate
Design and evaluation of four novel tripeptides as potent angiotensin converting enzyme (ACE) inhibitors with anti-hypertension activity
Where It Goes The injection is subcutaneous, given in the abdomen (avoiding a 2-inch radius around the belly button), upper outer thigh, or back of the upper arm
The liver plays a central role in metabolizing fats, carbohydrates, and proteins
YZH, MM, and HL wrote the first draft
This peptide was originally developed by Professor Frank Ng at Monash University in Australia during the 1990s as a potential anti-obesity treatment